{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:19:42Z","timestamp":1777072782288,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.avsg.2024.05.031","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T19:03:13Z","timestamp":1720983793000},"page":"338-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rivaroxaban and Aspirin in Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2758-8892","authenticated-orcid":false,"given":"Zhihong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huajie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2024.05.031_bib1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","article-title":"Peripheral artery disease: past, present, and future","volume":"132","author":"Campia","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.avsg.2024.05.031_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.05.031_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/14779072.2019.1675512","article-title":"Newly approved devices for endovascular treatment of femoropopliteal disease: a review of clinical evidence","volume":"17","author":"Giannopoulos","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.avsg.2024.05.031_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00380-021-01941-9","article-title":"Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons","volume":"37","author":"Yoshioka","year":"2021","journal-title":"Heart Ves"},{"key":"10.1016\/j.avsg.2024.05.031_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007559","article-title":"Femoropopliteal in-stent restenosis","volume":"11","author":"Rymer","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.05.031_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007055","article-title":"Drug-coated balloon angioplasty for femoropopliteal in-stent restenosis","volume":"11","author":"Cassese","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.05.031_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/17434440.2020.1770593","article-title":"Safety and efficacy of paclitaxel drug-coated balloon in femoropopliteal in-stent restenosis","volume":"17","author":"Anantha-Narayanan","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.avsg.2024.05.031_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4244\/EIJ-D-16-00735","article-title":"Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis","volume":"13","author":"Cassese","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.avsg.2024.05.031_bib9","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/CIRCULATIONAHA.115.017364","article-title":"Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized femoral artery in-stent restenosis (FAIR) trial","volume":"132","author":"Krankenberg","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.05.031_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.121.054835","article-title":"Effect of rivaroxaban and aspirin in patients with peripheral artery disease undergoing surgical revascularization: insights from the VOYAGER PAD trial","volume":"144","author":"Debus","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.05.031_bib11","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.121.055146","article-title":"Reduction in acute limb ischemia with rivaroxaban versus placebo in peripheral artery disease after lower extremity revascularization: insights from VOYAGER PAD","volume":"144","author":"Hess","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.05.031_bib12","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.avsg.2024.05.031_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1148\/radiol.2251011809","article-title":"Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis","volume":"225","author":"Schillinger","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.avsg.2024.05.031_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcin.2014.01.168","article-title":"Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery","volume":"7","author":"Iida","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.05.031_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0003319718799589","article-title":"Relationship between postoperative neutrophil-lymphocyte ratio and 6-month primary patency of percutaneous transluminal angioplasty in femoropopliteal disease with drug-coated and uncoated balloons","volume":"70","author":"Zhen","year":"2019","journal-title":"Angiology"},{"key":"10.1016\/j.avsg.2024.05.031_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2019.04.057","article-title":"Drug-eluting balloon versus drug-eluting stent for complex femoropopliteal arterial lesions: the DRASTICO study","volume":"74","author":"Liistro","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2024.05.031_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2024.05.031_bib18","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries","volume":"1","author":"Kayssi","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.avsg.2024.05.031_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jvir.2021.12.007","article-title":"Systematic review and meta-analysis of drug-coated balloon angioplasty for in-stent restenosis in femoropopliteal artery disease","volume":"33","author":"Zhen","year":"2022","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2024.05.031_bib20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jcin.2016.04.012","article-title":"Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial","volume":"9","author":"Kinstner","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2024.05.031_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijsu.2017.04.057","article-title":"Paclitaxel-coated versus uncoated balloon angioplasty for femoropopliteal artery in-stent restenosis","volume":"42","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.avsg.2024.05.031_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006321","article-title":"ISAR-PEBIS (Paclitaxel-Eluting balloon versus conventional balloon angioplasty for in-stent restenosis of superficial femoral artery): a randomized trial","volume":"6","author":"Ott","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2024.05.031_bib23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/17085381211013968","article-title":"Orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of femoropopliteal artery disease: 12-month result of the randomized controlled trial","volume":"30","author":"Liao","year":"2022","journal-title":"Vascular"},{"key":"10.1016\/j.avsg.2024.05.031_bib24","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624004187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624004187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T22:14:43Z","timestamp":1728512083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509624004187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"alternative-id":["S0890509624004187"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2024.05.031","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivaroxaban and Aspirin in Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2024.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}